Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2247 ARTÍCULOS , VIENDO DEL 2011 AL 2025

Neprilysin inhibitors and risk of Alzheimer's disease: A future perspective

Ali NH, Al-Kuraishy HM, Al-Gareeb AI, Alnaaim SA, Alexiou A, Papadakis M, Khalifa AA, Saad HM, Batiha GE.

J Cell Mol Med. 2024 Jan;28(2):e17993. doi: 10.1111/jcmm.17993. Epub 2023 Oct 17.

Advances in targeted tracking and detection of soluble amyloid-β aggregates as a biomarker of Alzheimer's disease

Gao H, Chen J, Huang Y, Zhao R.

Talanta. 2024 Feb 1;268(Pt 1):125311. doi: 10.1016/j.talanta.2023.125311. Epub 2023 Oct 14.

Comparative methods for quantifying plasma biomarkers in Alzheimer's disease: Implications for the next frontier in cerebral amyloid angiopathy diagnostics

Muir RT, Ismail Z, Black SE, Smith EE.

Alzheimers Dement. 2024 Feb;20(2):1436-1458. doi: 10.1002/alz.13510. Epub 2023 Oct 31.

Comparison of CSF and plasma NfL and pNfH for Alzheimer's disease diagnosis: a memory clinic study

Vrillon A, Ashton NJ, Karikari TK, Götze K, Cognat E, Dumurgier J, Lilamand M, Zetterberg H, Blennow K, Paquet C.

J Neurol. 2024 Mar;271(3):1297-1310. doi: 10.1007/s00415-023-12066-6. Epub 2023 Nov 11.

Innovative SALDI mass spectrometry analysis for Alzheimer's disease synthetic peptides detection

Cournut A, Moustiez P, Coffinier Y, Enjalbal C, Bich C.

Talanta. 2024 Feb 1;268(Pt 2):125357. doi: 10.1016/j.talanta.2023.125357. Epub 2023 Nov 2.

Correlations between insulin-degrading enzyme and metabolic markers in patients diagnosed with type 2 diabetes, Alzheimer's disease, and healthy controls: a comparative study

Kullenberg H, Rossen J, Johansson UB, Hagströmer M, Nyström T, Kumlin M, Svedberg MM.

Endocrine. 2024 May;84(2):450-458. doi: 10.1007/s12020-023-03603-4. Epub 2023 Nov 18.

Clusterin is a Potential Therapeutic Target in Alzheimer's Disease

Palihati N, Tang Y, Yin Y, Yu D, Liu G, Quan Z, Ni J, Yan Y, Qing H.

Mol Neurobiol. 2024 Jul;61(7):3836-3850. doi: 10.1007/s12035-023-03801-1. Epub 2023 Nov 29.

Associations between Alzheimer's disease biomarkers and postoperative delirium or cognitive dysfunction: A meta-analysis and trial sequential analysis of prospective clinical trials

Geng J, Zhang Y, Chen H, Shi H, Wu Z, Chen J, Luo F.

Eur J Anaesthesiol. 2024 Mar 1;41(3):234-244. doi: 10.1097/EJA.0000000000001933. Epub 2023 Dec 1.

Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer's disease

Abdelmaksoud NM, Sallam AM, Abulsoud AI, El-Dakroury WA, Abdel Mageed SS, Al-Noshokaty TM, Elrebehy MA, Elshaer SS, Mahmoud NA, Fathi D, Rizk NI, Elballal MS, Mohammed OA, Abdel-Reheim MA, Zaki MB, Saber S, Doghish AS.

Pathol Res Pract. 2024 Jan;253:155007. doi: 10.1016/j.prp.2023.155007. Epub 2023 Dec 4.

Harmonization of CSF and imaging biomarkers in Alzheimer's disease: Need and practical applications for genetics studies and preclinical classification

Timsina J, Ali M, Do A, Wang L, Western D, Sung YJ, Cruchaga C.

Neurobiol Dis. 2024 Jan;190:106373. doi: 10.1016/j.nbd.2023.106373. Epub 2023 Dec 9.

Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial

Cullen NC, Novak P, Tosun D, Kovacech B, Hanes J, Kontsekova E, Fresser M, Ropele S, Feldman HH, Schmidt R, Winblad B, Zilka N.

EBioMedicine. 2024 Jan;99:104923. doi: 10.1016/j.ebiom.2023.104923. Epub 2023 Dec 14.

Peripheral immune function and Alzheimer's disease: a living systematic review and critical appraisal

Li C, Stebbins RC, Noppert GA, Carney CX, Liu C, Sapp ARM, Watson EJ, Aiello AE.

Mol Psychiatry. 2024 Jun;29(6):1895-1905. doi: 10.1038/s41380-023-02355-x. Epub 2023 Dec 15.

Revision of Alzheimer's diagnostic criteria or relocation of the Potemkin village

Høilund-Carlsen PF, Alavi A, Barrio JR, Castellani RJ, Costa T, Herrup K, Kepp KP, Neve RL, Perry G, Revheim ME, Robakis NK, Sensi SL, Vissel B.

Ageing Res Rev. 2024 Jan;93:102173. doi: 10.1016/j.arr.2023.102173. Epub 2023 Dec 15.

Elevated Homocysteine Level and Brain Atrophy Changes as Markers to Screen the Alzheimer Disease: Case Series

Sah RP, Vidya CS, Pereira P, Jayaram S, Yadav AK, Sujatha P.

Ann Geriatr Med Res. 2024 Mar;28(1):116-120. doi: 10.4235/agmr.23.0135. Epub 2023 Dec 13.

High-Performance Plasma Biomarker Panel for Alzheimer's Disease Screening Using a Femtomolar-Level Label-Free Biosensing System

Wang S, Deng R, Chen Z, Huang L, Song Y, Yuan D, Li Y, Liu H, Yang F, Fan B, Xu Y, Zhao Z, Li Y, Zhang Y.

ACS Nano. 2024 Jan 23;18(3):2117-2130. doi: 10.1021/acsnano.3c09311. Epub 2023 Dec 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias